Maelstrom Research Staging | CPSS_AntenatalCohort1

CPSS_AntenatalCohort1_Serotest

Networks -

Variables -

Associated study CPSS-Antenatal Contingency Table

Population

CPSS-Antenatal - Cohort 1

The population is composed of pregnant women in all provinces and territories of Canada who have their prenatal serology results available in laboratories.

Selection Criteria

Sex

Women

Pregnant Women

First trimester

Newborns

Twins

Countries

Canada

Territory

Ethnic Origin

Health Status

Other Criteria

Had a routine blood screening of the antibody status to rubella, HIV, Hepatits B and syphilis

Recruitment

Sources of recruitment

Specific population

Specific Population

Clinic patients

Supplementary Information

Pregnant women who get a routine blood screening for prenatal care and who have their serological test results available for testing.

Number of Participants

Number of Participants: 18,000
Number of Participants with Biological Samples: 18,000
Supplementary Information about selection criteria

More info

Data Collection Event

CPSS-Antenatal - Cohort 1 - Serotest

Collected blood samples for prenatal serological survey were sequestered in November to December 2020 and tested for detection of SARS-CoV-2 from December 2020 to March 2021. Information on age, geocode, date and type of specimen, type of assay(s) used and titer result were obtained from administrative databases and linked to serosamples.

More info

Collected Dataset / CPSS_AntenatalCohort1_Serotest

CPSS_AntenatalCohort1_Serotest

Population

CPSS-Antenatal - Cohort 1

Data Collection Event

CPSS-Antenatal - Cohort 1 - Serotest

Files

Variables Classifications